A Transdisciplinary Panel on CRISPR/Cas9 2018-02-13 10:30:00

zurück zu Veranstaltungen

Start:Dienstag, 13 Februar 2018Zeit:10:30
Ende:Dienstag, 13 Februar 2018Zeit:12:30
Kategorie: Non-SCS events

Science Policy Session adipisicing as part of qui the LS2 Annual officia Meeting 2018:
- Martin Jinek, University of consequat. Zurich
- Bruno cupidatat Lemaitre, EPF Lausanne
- culpa Effy Vayena, Chair of fugiat Bioethics, Health Ethics mollit & Policy Lab, Dep. nulla of Health Sciences cupidatat & Technology, ETHZ)
- Heinz Müller, Swiss est Federal Institute of fugiat Intellectual Property, Bern
Moderation: Nik Walter consequat. (Tages-Anzeiger/SonntagsZeitung)

Ort: University of Lausanne, Amphimax/Amphipôle
Detailed DescriptionThe CRISPR/Cas9 revolution is widely being talked about these days. Apart from being a major scientific breakthrough, it also reveals how different fears and hopes are being handled by science, society, economy, and policy makers. The CRISPR/Cas9 system thus represents an ideal case to discuss the different implications of modern biomedical research, from economical, legal and ethical implications, to aspects of scientific impact and careers. The transdisciplinary panel will give the stage to experts from different fields to then discuss all these aspects around one technology.

Attendance to the panel only is free.
Please register for the panel until January, 5th, 2018 with an e-mail to info@ls2.ch
Email: Senden
Webseite: http://www.annual-meeting.ls2.ch
Die Veranstaltung ist öffentlich. jeder kann daran Teilnehmen und andere dafür einladen.
Spichiger David (Ersteller)